Balance sheet strengthened and core business focus sharpened, with Q1 EBITDA boosted by a major asset sale despite a 29% revenue decline. Guidance for improved core EBITDA in 2024 is maintained, and the Value Uplift Program is expected to deliver positive results from H2.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.